Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 8 Finished
-
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence
National Institute of Allergy and Infectious Diseases
8/2/21 → 7/31/22
Project: Research project
-
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
National Institute of Allergy and Infectious Diseases
6/15/15 → 5/31/21
Project: Research project
-
Prime shock and kill for HIV erradication
National Institute of Allergy and Infectious Diseases
2/15/14 → 4/30/23
Project: Research project
-
Enhancing control of HIV by inhibiting TRAILshort
National Institute of Allergy and Infectious Diseases
7/2/13 → 6/1/15
Project: Research project
-
-
Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and kill
Chandrasekar, A. P., Maynes, M. & Badley, A. D., 2024, In: Frontiers in Cellular and Infection Microbiology. 14, 1354502.Research output: Contribution to journal › Review article › peer-review
Open Access -
Ink-spiring innovations: 3D bioprinting skin models for disease discovery
Simoes Torigoe, R. M., Revzin, A., Badley, A. & Wyles, S., Feb 1 2024, In: Regenerative Medicine. 19, 2, p. 65-68 4 p.Research output: Contribution to journal › Editorial › peer-review
-
Maternal SARS-CoV-2 infection in pregnancy disrupts gene expression in Hofbauer cells with limited impact on cytotrophoblasts
Enninga, E. A. L., Quach, H. Q., Jang, J. S., de Araujo Correia, M. C. M., Fedyshyn, Y., Fedyshyn, B., Lemens, M., Littlefield, D., Behl, S., Sintim-Aboagye, E., Plazas, M. C. M., Cardenas, M. C., Chakraborty, S., Yamaoka, S., Ebihara, H., Pandey, A., Li, H., Badley, A. D., Johnson, E. L., Sun, J., & 3 others , Feb 2024, In: PLoS pathogens. 20, 2 February, e1011990.Research output: Contribution to journal › Article › peer-review
Open Access -
Vertical Transmission of SARS-CoV-2–Specific Antibodies and Cytokine Profiles in Pregnancy
Monroe, J. M., Quach, H. Q., Punia, S., Enninga, E. A. L., Fedyshyn, Y., Girsch, J. H., Fedyshyn, B., Lemens, M., Littlefield, D., Behl, S., Sintim-Aboagye, E., Mejia Plazas, M. C., Yamaoka, S., Ebihara, H., Pandey, A., Correia, C., Ung, C. Y., Li, H., Vassallo, R., Sun, J., & 7 others , Feb 15 2024, In: Journal of Infectious Diseases. 229, 2, p. 473-484 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: Results from the randomised phase 3' LIVE-AIR' trial
Temesgen, Z., Kelley, C. F., Cerasoli, F., Kilcoyne, A., Chappell, D., Durrant, C., Ahmed, O., Chappell, G., Catterson, V., Polk, C., Badley, A. & Marconi, V. C., Jun 1 2023, In: Thorax. 78, 6, p. 606-616 11 p.Research output: Contribution to journal › Article › peer-review
Open Access